熱門資訊> 正文

Enliven Therapeutics申请为股东出售643万股股票

2024-04-19 04:57

11 Good Energy, Inc.(ELVN) 0

Enliven Therapeutics (NASDAQ:ELVN) on Thursday filed a prospectus related to the proposed resale of about 6.43M shares of its common stock by selling stockholders.
This prospectus is not an offer to sell these securities.
SEC Filing

More on Enliven Therapeutics

Enliven Therapeutics Maybe Improving Kinase Inhibitors, But Too Early To Tell The Impact
Enliven Therapeutics announces $90M private placement to fund R&D activities
Seeking Alpha’s Quant Rating on Enliven Therapeutics
Historical earnings data for Enliven Therapeutics
Financial information for Enliven Therapeutics

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。